Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.47398 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.35429 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.36161 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.31831 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.32117 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.48971 | 56 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.50941 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.3494 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.34261 | 55 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.35393 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.33974 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.3489 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.36895 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.35269 | 55 |